Nurix Therapeutics NRIX
NASDAQ NRIX
$23.34 -0.37 (-1.56%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Nurix Therapeutics' Depreciation & Amortization (CF) was $2.26 million in fiscal Q2 2026 (quarter ended May 31, 2026), up 0.6% from $2.24 million a year earlier and up 2.7% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nurix Therapeutics' Depreciation & Amortization (CF) was $8.6 million through May 31, 2026, down 9.8% year-over-year; for FY2025 (ended Nov 30, 2025), it was $8.74 million, down 6.2% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 31.8% (FY2020 to FY2025).
  • In earlier fiscal years, Depreciation & Amortization (CF) was $9.32 million in FY2024 (+23.7%), $7.53 million in FY2023 (+40.8%), $5.35 million in FY2022 (+91.0%) and $2.8 million in FY2021 (+27.3%).
  • The fiscal Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) since fiscal Q1 2025.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in four of the last eight quarters, with growth averaging 3.4%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was fiscal Q2 2022 (growth of 116.7%); the worst was fiscal Q4 2025 (a decline of 16.8%).
  • Per Business Quant data, NRIX's Depreciation & Amortization (CF) in the three fiscal quarters before Q2 2026 was $2.2 million (Q1 2026), $2.12 million (Q4 2025) and $2.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Nurix Therapeutics 2.46 Bn 452.73 Mn - 2.26 Mn
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 2.26 Mn
Feb 28, 2026 2.20 Mn
Nov 30, 2025 2.12 Mn
Aug 31, 2025 2.03 Mn
May 31, 2025 2.24 Mn
Feb 28, 2025 2.35 Mn
Nov 30, 2024 2.55 Mn
Aug 31, 2024 2.39 Mn
May 31, 2024 2.33 Mn
Feb 29, 2024 2.05 Mn
Nov 30, 2023 1.93 Mn
Aug 31, 2023 1.95 Mn
May 31, 2023 1.90 Mn
Feb 28, 2023 1.75 Mn
Nov 30, 2022 1.62 Mn
Aug 31, 2022 1.50 Mn
May 31, 2022 1.30 Mn
Feb 28, 2022 991,000.00
Nov 30, 2021 767,000.00
Aug 31, 2021 700,000.00
API Access

Nurix Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NRIX&period=max&api_key=YOUR_API_KEY